Jason Kenneth Myers

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
CGRP receptor antagonists
- Patent number 9,708,297
- Issue date Jul 18, 2017
- Eli Lilly and Company
- David Andrew Coates
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CGRP receptor antagonists
- Patent number 9,637,495
- Issue date May 2, 2017
- Eli Lilly and Company
- David Andrew Coates
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazole pyrazolopyrimidines CRF1 receptor antagonists
- Patent number 8,030,304
- Issue date Oct 4, 2011
- Eli Lilly and Company
- Zhaogen Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 an...
- Patent number 7,868,014
- Issue date Jan 11, 2011
- Eli Lilly and Company
- Thomas Charles Britton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic compounds for the treatment of disease
- Patent number 7,001,900
- Issue date Feb 21, 2006
- Pfizer Inc.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic-substituted-heteroaryl compounds for the treatment of d...
- Patent number 6,919,359
- Issue date Jul 19, 2005
- Pfizer Inc.
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted azabicyclic moieties for the treatment of disease
- Patent number 6,869,946
- Issue date Mar 22, 2005
- Pfizer Inc.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted-aryl compounds for treatment of disease
- Patent number 6,852,716
- Issue date Feb 8, 2005
- Pfizer Inc.
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine-substituted heteroaryl moieties for treatment of disease
- Patent number 6,599,916
- Issue date Jul 29, 2003
- Pharmacia and Upjohn Company
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes...
- Patent number 6,562,816
- Issue date May 13, 2003
- Pharmacia and Upjohn Company
- Donn G. Wishka
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine-substituted heteroaryl moieties for treatment of disease
- Patent number 6,500,840
- Issue date Dec 31, 2002
- Pharmacia and Upjohn Company
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine-substituted heteroaryl moieties for treatment of disease
- Patent number 6,492,385
- Issue date Dec 10, 2002
- Pharmacia and Upjohn Company
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine-substituted aryl compounds for treatment of disease
- Patent number 6,492,386
- Issue date Dec 10, 2002
- Pharmacia and Upjohn Company
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine-substituted aryl compounds for treatment of disease
- Patent number 6,486,172
- Issue date Nov 26, 2002
- Pharmacia and Upjohn Company
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine-substituted aryl compounds for treatment of disease
- Patent number 6,479,510
- Issue date Nov 12, 2002
- Pharmacia and Upjohn Company
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CGRP RECEPTOR ANTAGONISTS
- Publication number 20170044138
- Publication date Feb 16, 2017
- Eli Lilly and Company
- David Andrew Coates
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CGRP RECEPTOR ANTAGONISTS
- Publication number 20170044163
- Publication date Feb 16, 2017
- Eli Lilly and Company
- David Andrew Coates
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiazole pyrazolopyrimidines CRF1 receptor antagonists
- Publication number 20100222339
- Publication date Sep 2, 2010
- Zhaogen Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-(Hetero)Aryl-3-Amino-Pyrrolidine Derivatives for Use as Mglur3 An...
- Publication number 20080300266
- Publication date Dec 4, 2008
- Eli Lilly and Company
- Thomas Charles Britton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Positive allosteric modulators of the nicotinic acetylcholine receptor
- Publication number 20080132551
- Publication date Jun 5, 2008
- Pfizer Inc.
- Bruce Nelsen Rogers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of attention defecit hyperactivity disorder
- Publication number 20050107425
- Publication date May 19, 2005
- Pfizer Inc.
- Bruce N. Rogers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds as radioligands for the diagnosis of disease
- Publication number 20040157878
- Publication date Aug 12, 2004
- Bruce Nelson Rogers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic compounds for the treatment of disease
- Publication number 20030236270
- Publication date Dec 25, 2003
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted-aryl compounds for treatment of disease
- Publication number 20030236279
- Publication date Dec 25, 2003
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic-substituted-heteroaryl compounds for the treatment of d...
- Publication number 20030207913
- Publication date Nov 6, 2003
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of d...
- Publication number 20030069296
- Publication date Apr 10, 2003
- Donn G. Wishka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATME...
- Publication number 20030069290
- Publication date Apr 10, 2003
- Donn G. Wishka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted azabicyclic moieties for the treatment of disease
- Publication number 20030055043
- Publication date Mar 20, 2003
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinuclidine-substituted heteroaryl moieties for treatment of disease
- Publication number 20020091135
- Publication date Jul 11, 2002
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinuclidine-substituted aryl compounds for treatment of disease
- Publication number 20020052389
- Publication date May 2, 2002
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinuclidine-substituted aryl compounds for treatment of disease
- Publication number 20020049225
- Publication date Apr 25, 2002
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinuclidine-substituted heteroaryl moieties for treatment of disease
- Publication number 20020042428
- Publication date Apr 11, 2002
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinuclidine-substituted heteroaryl moieties for treatment of disease
- Publication number 20020042429
- Publication date Apr 11, 2002
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinuclidine-substituted aryl compounds for treatment of disease
- Publication number 20020040035
- Publication date Apr 4, 2002
- Jason K. Myers
- C07 - ORGANIC CHEMISTRY

Jason Kenneth Myers

Person

Patents Grantslast 30 patents

CGRP receptor antagonists

CGRP receptor antagonists

Thiazole pyrazolopyrimidines CRF1 receptor antagonists

1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 an...

Azabicyclic compounds for the treatment of disease

Azabicyclic-substituted-heteroaryl compounds for the treatment of d...

Substituted azabicyclic moieties for the treatment of disease

Substituted-aryl compounds for treatment of disease

Quinuclidine-substituted heteroaryl moieties for treatment of disease

Substituted-heteroaryl-7-aza&#x0005B;2.2.1&#x0005D;bicycloheptanes...

Quinuclidine-substituted heteroaryl moieties for treatment of disease

Quinuclidine-substituted heteroaryl moieties for treatment of disease

Quinuclidine-substituted aryl compounds for treatment of disease

Quinuclidine-substituted aryl compounds for treatment of disease

Quinuclidine-substituted aryl compounds for treatment of disease

Patents Applicationslast 30 patents

CGRP RECEPTOR ANTAGONISTS

CGRP RECEPTOR ANTAGONISTS

Thiazole pyrazolopyrimidines CRF1 receptor antagonists

1-(Hetero)Aryl-3-Amino-Pyrrolidine Derivatives for Use as Mglur3 An...

Positive allosteric modulators of the nicotinic acetylcholine receptor

Treatment of attention defecit hyperactivity disorder

Compounds as radioligands for the diagnosis of disease

Azabicyclic compounds for the treatment of disease

Substituted-aryl compounds for treatment of disease

Azabicyclic-substituted-heteroaryl compounds for the treatment of d...

Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of d...

SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATME...

Substituted azabicyclic moieties for the treatment of disease

Quinuclidine-substituted heteroaryl moieties for treatment of disease

Quinuclidine-substituted aryl compounds for treatment of disease

Quinuclidine-substituted aryl compounds for treatment of disease

Quinuclidine-substituted heteroaryl moieties for treatment of disease

Quinuclidine-substituted heteroaryl moieties for treatment of disease

Quinuclidine-substituted aryl compounds for treatment of disease

Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes...